"survival outcome" trang 3 - tải miễn phí từ tailieunhanh
Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer
7    35    1
Statin use and breast cancer survival – a Swedish nationwide study

Statin use and breast cancer survival – a Swedish nationwide study
9    41    1
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions
14    77    1
Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study

Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: A retrospective study
9    47    1
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients

Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
11    44    1
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: A retrospective cohort study

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: A retrospective cohort study
11    49    1
MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

MYC and BCL2 overexpression is associated with a higher class of Memorial SloanKettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
11    93    1
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting

Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting
9    47    1
Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: A retrospective study

Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: A retrospective study
12    36    1
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
19    39    1
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
11    49    1
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: Successive lines of active chemotherapeutic agents
8    36    2
Porous tantalum rod implantation is associated with low survival rates in patients with type C2 osteonecrosis of the femoral head but has no effect on the clinical outcome of conversion total hip arthroplasty: A retrospective study with an average 8-year follow-up

Porous tantalum rod implantation is associated with low survival rates in patients with type C2 osteonecrosis of the femoral head but has no effect on the clinical outcome of conversion total hip arthroplasty: A retrospective study with an average 8-year follow-up
9    46    1
Fifty-six percent of proximal femoral cortical hypertrophies 6 to 10 years after Total hip arthroplasty with a short Cementless curved hip stem – a cause for concern

Fifty-six percent of proximal femoral cortical hypertrophies 6 to 10 years after Total hip arthroplasty with a short Cementless curved hip stem – a cause for concern
9    33    1
Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy

Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy
9    35    1
Cortical hypertrophy with a short, curved uncemented hip stem does not have any clinical impact during early follow-up

Cortical hypertrophy with a short, curved uncemented hip stem does not have any clinical impact during early follow-up
9    44    1
Poor lung ultrasound score in shock patients admitted to the ICU is associated with worse outcome

Poor lung ultrasound score in shock patients admitted to the ICU is associated with worse outcome
8    43    1
Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: A single-center retrospective study

Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: A single-center retrospective study
9    31    1
Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay

Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay
9    14    1
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: The NOA-18 trial

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: The NOA-18 trial
12    20    1